Therapeutics: News and Research on Glycemic Control

MeSH tree: E02.491

Diabetes outcomes worsen after insurance loss, study finds

Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & Science University.

Understanding GLP-1 signaling: A path to better therapies

About one in eight U.S. adults are currently taking a GLP-1 drug such as Ozempic, Wegovy, or Zepbound to treat diabetes, obesity, or other conditions, according to a KFF Health Tracking poll. But many suffer from significant ...

Using machine learning and big data in academic medicine

Two new studies from the Department of Computational Biomedicine at Cedars-Sinai are advancing what we know about using machine learning and big data to improve health care and medical research. Both studies were published ...

page 1 from 1